Enanta Pharmaceuticals, Inc. (ENTA) News
Track canonical SquawkNews coverage tagged to ENTA, Enanta Pharmaceuticals, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Enanta Enters $75 Million At-the-Market Stock Offering Agreement
() -- Enanta Pharmaceuticals (ENTA) said Thursday it entered into an at-the-market offering agreement under which it may offer and sell up to $75 million of its common stock from time to time. The company said it has no
EQUITY | Jul 02, 2026, 09:26 PM UTC
L
Enanta Pharmaceuticals Enters Open Market Sale Agreement With Jefferies; May Offer And Sell Up To $75M Of Common Stock Through Jefferies
SEC Filing
REGULATION | Jul 02, 2026, 08:58 PM UTC
L
Enanta Appeals Paxlovid Suit
Enanta files notice of appeal in Paxlovid lawsuit against Pfizer
EQUITY | Jun 23, 2026, 09:36 PM UTC
H
ENTA: AbbVie Gets EU Approval
Enanta Pharmaceuticals' partner AbbVie receives European Commission approval of MAVIRET for people with acute Hepatitis C Virus
EQUITY | Jun 23, 2026, 09:23 AM UTC